Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Buys 43,401 Shares

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk purchased 43,401 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The shares were purchased at an average cost of $0.91 per share, with a total value of $39,494.91. Following the completion of the acquisition, the director owned 628,863 shares in the company, valued at $572,265.33. The trade was a 7.41% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

Myomo Stock Performance

NYSEAMERICAN:MYO opened at $0.84 on Tuesday. The stock has a market cap of $32.42 million, a P/E ratio of -2.33 and a beta of 1.39. The stock has a 50 day simple moving average of $0.76 and a 200 day simple moving average of $0.84. The company has a current ratio of 2.73, a quick ratio of 2.36 and a debt-to-equity ratio of 1.21. Myomo, Inc. has a 1-year low of $0.61 and a 1-year high of $3.45.

Wall Street Analyst Weigh In

Separately, Craig Hallum reissued a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $7.67.

Hedge Funds Weigh In On Myomo

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. XTX Topco Ltd acquired a new position in Myomo in the 4th quarter valued at $148,000. AQR Capital Management LLC raised its holdings in Myomo by 47.8% in the 4th quarter. AQR Capital Management LLC now owns 434,376 shares of the company’s stock valued at $395,000 after acquiring an additional 140,427 shares in the last quarter. State Street Corp raised its holdings in Myomo by 5.1% in the 4th quarter. State Street Corp now owns 399,853 shares of the company’s stock valued at $364,000 after acquiring an additional 19,563 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Myomo by 103.1% in the 4th quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock valued at $35,000 after acquiring an additional 19,646 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in Myomo in the 4th quarter valued at $64,000. 44.99% of the stock is owned by institutional investors and hedge funds.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.